Cargando…
LigBuilder V3: A Multi-Target de novo Drug Design Approach
With the rapid development of systems-based pharmacology and poly-pharmacology, method development for rational design of multi-target drugs has becoming urgent. In this paper, we present the first de novo multi-target drug design program LigBuilder V3, which can be used to design ligands to target...
Autores principales: | Yuan, Yaxia, Pei, Jianfeng, Lai, Luhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059350/ https://www.ncbi.nlm.nih.gov/pubmed/32181242 http://dx.doi.org/10.3389/fchem.2020.00142 |
Ejemplares similares
-
Structure-based de novo drug design using 3D deep generative models
por: Li, Yibo, et al.
Publicado: (2021) -
Computational Chemical Synthesis Analysis and Pathway Design
por: Feng, Fan, et al.
Publicado: (2018) -
The Mu.Ta.Lig. Chemotheca: A Community-Populated Molecular Database for Multi-Target Ligands Identification and Compound-Repurposing
por: Ortuso, Francesco, et al.
Publicado: (2018) -
LigAdvisor: a versatile and user-friendly web-platform for drug design
por: Pinzi, Luca, et al.
Publicado: (2021) -
Identification of LIG1 and LIG3 as prognostic biomarkers in breast cancer
por: Sun, Lin, et al.
Publicado: (2021)